Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Symbotic, Inc. (“Symbotic”) (NASDAQ: SYM) Class A common stock between November 20, 2023 and February 5, 2025, inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about Symbotic’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Symbiotic improperly accelerated its revenue recognition in its second and third quarter 2024 financial statements; (2) Symbotic had a material weakness in its internal controls over financial reporting; and (3) as a result of the foregoing, Defendants’ statements about Symbotic’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Current Status of Case:
On September 11, 2025, Defendants filed a Motion to Dismiss the Complaint. The Motion has been fully briefed and is pending decision before the Court. This action is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.